Topo Target ApS
Records under this name other than patents Topo Target ApS holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 4 of 4 · Back to Topo Target ApS
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 6,727,253 | Treatment of accidental extravasation of anthracyclines Formerly held Term ended Term ended Mar 13, 2020 · From the USPTO record | Term ended | Term ended Mar 13, 2020 | From the USPTO record |
| US 9,006,426 | Squaric acid derivatives as inhibitors of the nicotinamide Formerly held Lapsed on the fee record Ended Apr 14, 2019 · From the USPTO record | Lapsed on the fee record | Ended Apr 14, 2019 | From the USPTO record |
| US 6,265,385 | Topoisomerase II poison and bis-dioxopiperazine derivative combination therapy Formerly held Term ended Term ended Mar 8, 2019 · From the USPTO record | Term ended | Term ended Mar 8, 2019 | From the USPTO record |
| US 8,871,747 | Urea and thiourea derivatives Formerly held Lapsed on the fee record Ended Oct 28, 2018 · From the USPTO record | Lapsed on the fee record | Ended Oct 28, 2018 | From the USPTO record |